# Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19

> **NCT04826822** · PHASE3 · UNKNOWN · sponsor: **Chita State Regional Clinical Hospital Number 1** · enrollment: 440 (estimated)

## Conditions studied

- Coronavirus Infection
- Pneumonia, Viral

## Interventions

- **DRUG:** Spironolactone + Dexamethasone
- **DRUG:** Standard-of-care SARS-CoV-2 treatment

## Key facts

- **NCT ID:** NCT04826822
- **Lead sponsor:** Chita State Regional Clinical Hospital Number 1
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-24
- **Primary completion:** 2021-07-08
- **Final completion:** 2021-09-02
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2021-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04826822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04826822, "Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04826822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*